The Center for Opioid Research and Education is a consortium of physicians, nurses, pharmacists and patients who together created procedure specific opioid prescribing guidelines. In 2017, the consortium published guidelines offering consensus recommendations for the range of appropriate opioid prescribing following 20 common surgical procedures, and in 2018 published guidelines for 14 common dental procedures.
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Arizona piloted a multi-faceted initiative intended to reduce prescription drug misuse and abuse in 4 counties between July of 2012 and December 2013. This evaluation of the pilot from the Arizona Criminal Justice Commission found that the pilot delivered results including reduced
Health care providers often request guidance on how to have conversations with patients about opioids, pain treatment, addiction and other topics that may be challenging. In this collection, we have gathered materials that provide support to providers as they have these difficult conversations.
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities implement a program to promote responsible prescribing and dispensing policies and practices.
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities implement a program to reduce illicit acquisition and diversion of prescription drugs.
The Arizona legislature adopted a law requiring health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. Their implementation resources are included in the CLOUD and links to the project website and implementation documents are available below.
This 2018 guidance on telemedicine to prescribe buprenorphine was recently promoted by the Substance Abuse and Mental Health Services Administration (SAMHSA) as part of its Covid-19 public health emergency response. The guidance explains how telemedicine can be a solution to the lack of providers with a Drug Enforcement Administration waiver to prescribe buprenorphine. Part of a series of guidance letters issued by SAMSHA in March, 2020. Funding Source: U.S. Department of Health and Human Services
This 2018 toolkit from the California Quality Collaborative and Smart Care California provides step-by-step guidance for provider organizations to change provider behavior and culture around opioids. The toolkit is organized around 4 key strategies:
The 2017 Nebraska Pain Management Guidance document was developed by an expert advisory task force consisting of actively practicing clinicians and prescribers, public health officers and senior state officials. The guidance is notable for addressing a broad range of topics including